Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
<p>Abstract</p> <p>Background</p> <p>To assess the outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with a high risk of lo...
Main Authors: | Narita Shintaro, Tsuchiya Norihiko, Kumazawa Teruaki, Maita Shinya, Numakura Kazuyuki, Obara Takashi, Tsuruta Hiroshi, Saito Mitsuru, Inoue Takamitsu, Horikawa Yohei, Satoh Shigeru, Nanjyo Hiroshi, Habuchi Tomonori |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/1 |
Similar Items
-
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
by: Yoshinori Matsuda, et al.
Published: (2020-04-01) -
Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer
by: K. M. Nyushko, et al.
Published: (2017-10-01) -
NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE
by: T. V. Ustinova, et al.
Published: (2018-10-01) -
Estramustine-Induced Suicidal Erythrocyte Death
by: Rosi Bissinger, et al.
Published: (2013-11-01) -
Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
by: Takeshi Sasaki, et al.
Published: (2021-04-01)